RNA-seq analysis identifies transcriptomic profiles associated with anal cancer recurrence among people living with HIV
暂无分享,去创建一个
S. Shrestha | H. Wiener | G. Burkholder | S. Sudenga | O. Mamaeva | Y. Ye | Anna Junkins | M. Khushman | S. Al Diffalha | Kevin J. Maroney | Anju Bansal | Staci L Sudenga | Sameer Al Diffalha
[1] R. Pfeiffer,et al. Impact of HIV on Anal Squamous Cell Carcinoma Rates in the United States, 2001-2015. , 2022, Journal of the National Cancer Institute.
[2] A. Marzi,et al. Transcriptional Analysis of Infection With Early or Late Isolates From the 2013–2016 West Africa Ebola Virus Epidemic Does Not Suggest Attenuated Pathogenicity as a Result of Genetic Variation , 2021, Frontiers in Microbiology.
[3] M. Fernández-Zapico,et al. Hedgehog/GLI Signaling Pathway: Transduction, Regulation, and Implications for Disease , 2021, Cancers.
[4] R. Lin,et al. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis , 2021, BMC Genomics.
[5] Neil A. Miller,et al. Factors affecting migration to GRCh38 in laboratories performing clinical next-generation sequencing. , 2021, The Journal of molecular diagnostics : JMD.
[6] Fangkun Liu,et al. CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis , 2021, Frontiers in Oncology.
[7] Fengfeng Wang,et al. Long non-coding RNA SOX21-AS1 modulates lung cancer progress upon microRNA miR-24-3p/PIM2 axis , 2021, Bioengineered.
[8] Shu-juan Xie,et al. RNA sequencing: new technologies and applications in cancer research , 2020, Journal of Hematology & Oncology.
[9] Lanzhen Li,et al. Long non‐coding RNA SOX21‐AS1 enhances the stemness of breast cancer cells via the Hippo pathway , 2020, FEBS open bio.
[10] S. H. Park,et al. The Role of Autophagy in Skin Fibroblasts, Keratinocytes, Melanocytes, and Epidermal Stem Cells. , 2020, The Journal of investigative dermatology.
[11] Dan-dan Zhao,et al. Identification of differentially expressed metastatic genes and their signatures to predict the overall survival of uveal melanoma patients by bioinformatics analysis. , 2020, International journal of ophthalmology.
[12] D. Tibboel,et al. SOX21 modulates SOX2-initiated differentiation of epithelial cells in the extrapulmonary airways , 2020, bioRxiv.
[13] Chunlei Yuan,et al. SNORA71B promotes breast cancer cells across blood–brain barrier by inducing epithelial-mesenchymal transition , 2020, Breast Cancer.
[14] Qiu-ming He,et al. LncRNA SNHG17 aggravated prostate cancer progression through regulating its homolog SNORA71B via a positive feedback loop , 2020, Cell Death & Disease.
[15] Yue Xu,et al. MicroRNA-4316 inhibits gastric cancer proliferation and migration via directly targeting VEGF-A , 2020, Cancer Cell International.
[16] Linjia Su,et al. Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes , 2019, Journal of Experimental & Clinical Cancer Research.
[17] J. Palefsky,et al. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015. , 2019, Journal of the National Cancer Institute.
[18] Yan Zhou,et al. Long noncoding RNA SOX21‐AS1 promotes cervical cancer progression by competitively sponging miR‐7/VDAC1 , 2019, Journal of cellular physiology.
[19] Steven L Salzberg,et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.
[20] Alireza Hadj Khodabakhshi,et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.
[21] Yu Yang,et al. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316. , 2018, Biochemical and biophysical research communications.
[22] F. Wang,et al. Circular RNA circMYO9B facilitates breast cancer cell proliferation and invasiveness via upregulating FOXP4 expression by sponging miR-4316. , 2018, Archives of biochemistry and biophysics.
[23] Benno Schwikowski,et al. The Cytoscape Automation app article collection , 2018, F1000Research.
[24] Y. Chung,et al. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus. , 2018, Human pathology.
[25] Harrison Pielke-Lombardo,et al. GSEA-InContext: identifying novel and common patterns in expression experiments , 2018, bioRxiv.
[26] R. Pfeiffer,et al. Anal Cancer Risk Among People With HIV Infection in the United States. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] D. Hussein,et al. Comprehensive molecular biomarker identification in breast cancer brain metastases , 2017, Journal of Translational Medicine.
[28] Jing Wang,et al. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal , 2017, Molecular Cancer Research.
[29] Toby C. Cornish,et al. Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy , 2017, JAMA oncology.
[30] E. Bahassi,et al. Comparative molecular profiling of HPV‐induced squamous cell carcinomas , 2017, Cancer medicine.
[31] P. Krawczyk,et al. Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer , 2017, International Journal of Colorectal Disease.
[32] W. Dougall,et al. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy , 2017, Immunological reviews.
[33] Z. Lu,et al. RNA Biomarkers: Frontier of Precision Medicine for Cancer , 2017, Non-coding RNA.
[34] Brian C. Jackson,et al. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2 , 2017, Journal of the National Cancer Institute.
[35] P. Agostinis,et al. DAMP—Induced Allograft and Tumor Rejection: The Circle Is Closing , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[36] Y. Shiue,et al. Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer , 2016, Clinical Epigenetics.
[37] G. Getz,et al. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma , 2016, Clinical Cancer Research.
[38] H. Katki,et al. Cancer risk among the HIV-infected elderly in the United States , 2016, AIDS.
[39] James X. Sun,et al. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[40] Z. Gatalica,et al. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas , 2015, Oncotarget.
[41] R. Pfeiffer,et al. Excess cancers among HIV-infected people in the United States. , 2015, Journal of the National Cancer Institute.
[42] H. Kourie,et al. Anal cancer treatment: current status and future perspectives. , 2015, World journal of gastroenterology.
[43] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[44] T. Fujiwara,et al. Peptide intra-tumor injection for cancer immunotherapy , 2013, Human vaccines & immunotherapeutics.
[45] G. Srikrishna. S100A8 and S100A9: New Insights into Their Roles in Malignancy , 2011, Journal of Innate Immunity.
[46] J. Ledermann,et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I) , 2010, British Journal of Cancer.
[47] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[48] W. Chazin,et al. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. , 2009, European journal of pharmacology.
[49] S. Cole,et al. A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals , 2009, Journal of acquired immune deficiency syndromes.
[50] D. Foell,et al. The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer , 2009, Journal of leukocyte biology.
[51] R. Biggar,et al. Risk of human papillomavirus-associated cancers among persons with AIDS. , 2009, Journal of the National Cancer Institute.
[52] J. Bendell,et al. Anal cancer: an overview. , 2007, The oncologist.
[53] P. Angel,et al. S100A8 and S100A9 in inflammation and cancer. , 2006, Biochemical pharmacology.
[54] M. Katoh,et al. Hedgehog signaling pathway and gastric cancer , 2005, Cancer biology & therapy.
[55] M. Stamos,et al. Patterns of recurrence in anal canal carcinoma. , 2000, Archives of surgery.
[56] R. Hollingsworth,et al. PTCH2, a novel human patched gene, undergoing alternative splicing and up-regulated in basal cell carcinomas. , 1999, Cancer research.
[57] H. Bartelink,et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] R. James. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin , 1996, The Lancet.
[59] G. Tanum. [Anal cancer. A review]. , 1996, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.